Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Hamill Laura (CIK 1751804) reported 8 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Sell JAZZ (14 shares), Sell JAZZ (1,692 shares), Buy JAZZ (1,605 shares), Sell YMAB (5,825 shares), Sell YMAB (25,080 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 14 | $3,417 |
| 2026-09-02 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,692 | $408,432 |
| 2026-08-07 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 1,605 | $0 |
| 2025-09-19 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 5,825 | $50,095 |
| 2025-09-19 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 25,080 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,805 | $200,806 |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Buy | 25,080 | $0 |
Source: SEC Form 4 filings · as of 2026-09-02